Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Head-to-head comparison of insulin glargine U300 vs insulin degludec in type 1 diabetes
2016-002725-11Phase 4Completed
- Sponsor
- University of Perugia
- Start
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin glargine and insulin degludec in diabetes mellitus type 1 (T1D) (2 arms), sponsored by University of Perugia. Started Jun 2021; status: completed.
02
Drugs
insulin glargineinsulin degludec
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2016-002725-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002725-11.